Jeremy M. Levin - 26 Feb 2026 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role: Director
Signature: /s/ Jeremy Levin
Issuer symbol: OVID
Transactions as of: 26 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 02 Mar 2026, 16:30:17 UTC
Previous filing: 18 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
LEVIN JEREMY M	Director	C/O OVID THERAPEUTICS INC., 441 NINTH AVENUE, 14TH FLOOR, NEW YORK	/s/ Jeremy Levin	02 Mar 2026	0001256153

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OVID	Employee Stock Option (Right to Buy)	Award	$0	+957,000		$0.000000	957,000	26 Feb 2026	Common Stock	957,000	$1.65	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the stock option will vest in 48 equal monthly installments commencing on March 20, 2026, subject to the Reporting Person's continued services through each such date.